Clearmind Medicine Common Stock Analysis

Clearmind Stock Analysis Notes

About 14.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Clearmind Medicine Common recorded a loss per share of 1.69. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 28th of November 2023. For more info on Clearmind Medicine Common please contact the company at 973 536 1016 or go to https://www.clearmindmedicine.com.

Clearmind Medicine Common Investment Alerts

Clearmind Medicine Thematic Classifications

Clearmind Stock Institutional Investors

Note, although Clearmind Medicine's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Clearmind Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.35 M.

Clearmind Profitablity

Management Efficiency

Clearmind Medicine Common has return on total asset (ROA) of (0.5437) % which means that it has lost $0.5437 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.5689) %, meaning that it created substantial loss on money invested by shareholders. Clearmind Medicine's management efficiency ratios could be used to measure how well Clearmind Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of March 18, 2025, Return On Tangible Assets is expected to decline to -0.89. The current year's Return On Capital Employed is expected to grow to -2.2. At present, Clearmind Medicine's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 8.6 M, whereas Non Currrent Assets Other are forecasted to decline to 6,144.

Technical Drivers

As of the 18th of March 2025, Clearmind Medicine shows the risk adjusted performance of (0), and Mean Deviation of 3.9. Clearmind Medicine Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Clearmind Medicine Common standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Clearmind Medicine Common is priced correctly, providing market reflects its regular price of 1.14 per share. Given that Clearmind Medicine is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Clearmind Medicine Common Price Movement Analysis

Clearmind Medicine Common Insider Trading Activities

Clearmind Medicine Predictive Daily Indicators

Clearmind Medicine Forecast Models

Clearmind Medicine's time-series forecasting models are one of many Clearmind Medicine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clearmind Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Clearmind Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Clearmind shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Clearmind Medicine. By using and applying Clearmind Stock analysis, traders can create a robust methodology for identifying Clearmind entry and exit points for their positions.

When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.